Swedbank’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $29M | Sell |
|
|||||
|
2025
Q2 | $21M | Buy |
|
|||||
|
2025
Q1 | $16.2M | Buy |
|
|||||
|
2024
Q4 | $13.1M | Buy |
|
|||||
|
2024
Q3 | $14.8M | Buy |
|
|||||
|
2024
Q2 | $5.02M | Hold |
|
|||||
|
2024
Q1 | $3.08M | Sell |
|
|||||
|
2023
Q4 | $42.2M | Hold |
|
|||||
|
2023
Q3 | $39.1M | Sell |
|
|||||
|
2023
Q2 | $63.4M | Hold |
|
|||||
|
2023
Q1 | $66.9M | Sell |
|
|||||
|
2022
Q4 | $101M | Buy |
|
|||||
|
2022
Q3 | $83.3M | Sell |
|
|||||
|
2022
Q2 | $64.1M | Buy |
|
|||||
|
2022
Q1 | $71.6M | Buy |
|
|||||
|
2021
Q4 | $74.7M | Buy |
|
|||||
|
2021
Q3 | $82.4M | Buy |
|
|||||
|
2021
Q2 | $58.6M | Buy |
|
|||||
|
2021
Q1 | $48M | Buy |
|